Natural History of Cardiac and Peripheral Vascular Death In ESKD: An Australian And New Zealand Data Linkage Study
Introduction Cardiovascular disease is a leading cause of death in patients with end-stage kidney disease (ESKD). However, ascertaining the impact of cardiovascular deaths has not been well characterised over long periods of follow-up and across different treatment states. Further insights into the...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Swansea University
2020-12-01
|
Series: | International Journal of Population Data Science |
Online Access: | https://ijpds.org/article/view/1587 |
id |
doaj-036993f583a44fad89d76747e4c393c4 |
---|---|
record_format |
Article |
spelling |
doaj-036993f583a44fad89d76747e4c393c42021-02-10T16:42:08ZengSwansea UniversityInternational Journal of Population Data Science2399-49082020-12-015510.23889/ijpds.v5i5.1587Natural History of Cardiac and Peripheral Vascular Death In ESKD: An Australian And New Zealand Data Linkage StudyVictor Khou0VictorNicole L De La Mat1Patrick J Kelly2Angela C Webster3Sydney School of Public HealthSydney School of Public HealthSydney School of Public HealthSydney School of Public Health; Centre for Renal and Transplant Research, Westmead Hospital Introduction Cardiovascular disease is a leading cause of death in patients with end-stage kidney disease (ESKD). However, ascertaining the impact of cardiovascular deaths has not been well characterised over long periods of follow-up and across different treatment states. Further insights into the lifetime risk of cardiovascular death are required to better inform clinical practice and economic planning. Objectives and Approach We performed a population-based cohort study on incident patients receiving ESKD treatment from the Australian and New Zealand Dialysis and Transplant registry (ANZDATA). Cardiac/vascular deaths were determined from ICD-10-AM codes listed in the underlying cause of death obtained via data linkage with the Australian National Death Index and New Zealand Mortality Collection database. We estimated mortality rates from cardiac/vascular death across time from ESKD treatment, and calculated probability of death and transplant status over time using multistate models. Results Across 60,823 incident ESKD patients and 381,874 person-years of follow-up, 22% (7,551) of deaths were from cardiac/vascular disease. At 15 years from treatment, 15.6% of patients had died from cardiac/vascular causes, most of whom never received a transplant (13.6% vs 2.0% of cohort). Within the first year of dialysis, cardiac/vascular mortality was highest in the second month, at 3,632/100,000pys. Improvements in cardiac/vascular mortality with calendar year were only seen after 9 months of dialysis. Transplant recipients had consistently lower cardiac/vascular mortality rates (598/100,000 pys) compared to dialysis patients. However, comorbid cardiovascular disease was a risk factor for graft failure and death in transplant recipients (HR:1.52, 95% CI:1.42-1.62). Conclusion / Implications Despite improvements in cardiac/vascular outcomes over time, cardiovascular death remains common in ESKD, particularly in the first few months of treatment. A greater focus on secondary prevention in earlier stages of chronic kidney disease may improve outcomes in new ESKD patients. https://ijpds.org/article/view/1587 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Victor Khou VictorNicole L De La Mat Patrick J Kelly Angela C Webster |
spellingShingle |
Victor Khou VictorNicole L De La Mat Patrick J Kelly Angela C Webster Natural History of Cardiac and Peripheral Vascular Death In ESKD: An Australian And New Zealand Data Linkage Study International Journal of Population Data Science |
author_facet |
Victor Khou VictorNicole L De La Mat Patrick J Kelly Angela C Webster |
author_sort |
Victor Khou |
title |
Natural History of Cardiac and Peripheral Vascular Death In ESKD: An Australian And New Zealand Data Linkage Study |
title_short |
Natural History of Cardiac and Peripheral Vascular Death In ESKD: An Australian And New Zealand Data Linkage Study |
title_full |
Natural History of Cardiac and Peripheral Vascular Death In ESKD: An Australian And New Zealand Data Linkage Study |
title_fullStr |
Natural History of Cardiac and Peripheral Vascular Death In ESKD: An Australian And New Zealand Data Linkage Study |
title_full_unstemmed |
Natural History of Cardiac and Peripheral Vascular Death In ESKD: An Australian And New Zealand Data Linkage Study |
title_sort |
natural history of cardiac and peripheral vascular death in eskd: an australian and new zealand data linkage study |
publisher |
Swansea University |
series |
International Journal of Population Data Science |
issn |
2399-4908 |
publishDate |
2020-12-01 |
description |
Introduction
Cardiovascular disease is a leading cause of death in patients with end-stage kidney disease (ESKD). However, ascertaining the impact of cardiovascular deaths has not been well characterised over long periods of follow-up and across different treatment states. Further insights into the lifetime risk of cardiovascular death are required to better inform clinical practice and economic planning.
Objectives and Approach
We performed a population-based cohort study on incident patients receiving ESKD treatment from the Australian and New Zealand Dialysis and Transplant registry (ANZDATA). Cardiac/vascular deaths were determined from ICD-10-AM codes listed in the underlying cause of death obtained via data linkage with the Australian National Death Index and New Zealand Mortality Collection database. We estimated mortality rates from cardiac/vascular death across time from ESKD treatment, and calculated probability of death and transplant status over time using multistate models.
Results
Across 60,823 incident ESKD patients and 381,874 person-years of follow-up, 22% (7,551) of deaths were from cardiac/vascular disease. At 15 years from treatment, 15.6% of patients had died from cardiac/vascular causes, most of whom never received a transplant (13.6% vs 2.0% of cohort). Within the first year of dialysis, cardiac/vascular mortality was highest in the second month, at 3,632/100,000pys. Improvements in cardiac/vascular mortality with calendar year were only seen after 9 months of dialysis. Transplant recipients had consistently lower cardiac/vascular mortality rates (598/100,000 pys) compared to dialysis patients. However, comorbid cardiovascular disease was a risk factor for graft failure and death in transplant recipients (HR:1.52, 95% CI:1.42-1.62).
Conclusion / Implications
Despite improvements in cardiac/vascular outcomes over time, cardiovascular death remains common in ESKD, particularly in the first few months of treatment. A greater focus on secondary prevention in earlier stages of chronic kidney disease may improve outcomes in new ESKD patients.
|
url |
https://ijpds.org/article/view/1587 |
work_keys_str_mv |
AT victorkhou naturalhistoryofcardiacandperipheralvasculardeathineskdanaustralianandnewzealanddatalinkagestudy AT victornicoleldelamat naturalhistoryofcardiacandperipheralvasculardeathineskdanaustralianandnewzealanddatalinkagestudy AT patrickjkelly naturalhistoryofcardiacandperipheralvasculardeathineskdanaustralianandnewzealanddatalinkagestudy AT angelacwebster naturalhistoryofcardiacandperipheralvasculardeathineskdanaustralianandnewzealanddatalinkagestudy |
_version_ |
1724275136099516416 |